Please assess the completion status of the following clinical trial:

Trial Title: Ex Vivo Stimulation of Whole Blood as a Means to Determine Glucocorticoid Sensitivity to Mild-to-Moderate and Refractory Asthmatics

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~To be eligible for the study, subjects must meet all of the following criteria:~* Age ≥ 18 years old~* Physician diagnosis of asthma confirmed through medical record documentation.~* Documented history of 12% FEV1 reversibility post-bronchodilator and/or Methacholine PC 20 score of 16mg/ml or less.~* Non-smoker for \> 6 months before enrollment into the trial~* Less than 5 pack year smoking history defined as the average packs smoked per day multiplied by the years of active smoking.~* Willing and able to adhere to the study visit schedule and other protocol-specified procedures.~Exclusion criteria:~Subjects meeting any of the following criteria may not be enrolled in the study:~* Existence of lung disease (other than asthma)~* Recent asthma exacerbation requiring hospital admissions, unexpected healthcare visits, or prednisone courses in the previous 4 weeks.~* Non-English speaking.~* Participation in another interventional research trial~* Self-reported pregnancy~* Inability or unwillingness to provide consent~* Febrile illness (\>38.0˚ C or 100.4˚ F) within 24 hours of visit.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).